SCHEMBL17641863

SCHEMBL17641863

COc1ccc(OC)c(-c2ccc(-c3ccc(-c4ccc(-c5cc(OC)ccc5OC)s4)c4nsnc34)s2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 3/20 0.45
▸ CYP1B1 Q16678 3/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ CYP2E1 P05181 2/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2C8 P10632 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2A6 P11509 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP4B1 P13584 2/20 0.45
▸ CYP2B6 P20813 2/20 0.45
▸ CYP3A5 P20815 2/20 0.45
▸ CYP2A7 P20853 2/20 0.45
▸ CYP3A7 P24462 2/20 0.45
▸ CYP2F1 P24903 2/20 0.45
▸ CYP2C18 P33260 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP2J2 P51589 2/20 0.45
▸ CYP4F2 P78329 2/20 0.45
▸ CYP4F8 P98187 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17642170 0.90 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL24478431 0.86 CA12 (0.47) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL20806065 0.82 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL14515080 0.80 APP (0.71) CYP1A2APPMEN1KMT2ANPC1
SCHEMBL23000124 0.79 HSD17B1 (0.45) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL25070453 0.78 CYP1A1 (0.51) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL24478312 0.78 CYP1A1 (0.51) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL17642062 0.76 APP (0.50) CYP3A4APPCA1CA2CA7
SCHEMBL25070530 0.75 APP (0.42) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4
SCHEMBL19682268 0.74 APP (0.41) CYP1A1CYP1B1CYP1A2CYP2E1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782279-B1 LUMINESCENT SOLAR CONCENTRATORS OF NEUTRAL COLORATION ENI SPA (IT) 2024-11-13 — — EP claimed
CN-112020825-B Neutral colored luminescent solar concentrator 艾尼股份公司 2024-06-11 — — CN claimed
US-20230395739-A1 ACHROMATIC LUMINESCENT SOLAR CONCENTRATORS ENI S.P.A. (IT) 2023-12-07 — — US claimed
US-11800728-B2 Luminescent solar concentrators of neutral coloration ENI S.P.A. (IT) 2023-10-24 — — US claimed
EP-4229684-A1 ACHROMATIC LUMINESCENT SOLAR CONCENTRATORS ENI S.p.A. (IT) 2023-08-23 — — EP claimed
CN-116324113-A Colorless luminous solar energy condenser 埃尼股份公司 2023-06-23 — — CN claimed
WO-2022079624-A1 ACHROMATIC LUMINESCENT SOLAR CONCENTRATORS ENI S.P.A. (IT) 2022-04-21 — — WO claimed
US-20210111360-A1 LUMINESCENT SOLAR CONCENTRATORS OF NEUTRAL COLORATION ENI S.P.A. (IT) 2021-04-15 — — US claimed
CN-112020825-A Neutral pigmented luminescent solar concentrators 艾尼股份公司 2020-12-01 — — CN claimed
CN-112020825-B Neutral colored luminescent solar concentrator 艾尼股份公司 2024-06-11 — — CN disclosed
US-20230395739-A1 ACHROMATIC LUMINESCENT SOLAR CONCENTRATORS ENI S.P.A. (IT) 2023-12-07 — — US disclosed
US-11800728-B2 Luminescent solar concentrators of neutral coloration ENI S.P.A. (IT) 2023-10-24 — — US disclosed
EP-4229684-A1 ACHROMATIC LUMINESCENT SOLAR CONCENTRATORS ENI S.p.A. (IT) 2023-08-23 — — EP disclosed
WO-2022079624-A1 ACHROMATIC LUMINESCENT SOLAR CONCENTRATORS ENI S.P.A. (IT) 2022-04-21 — — WO disclosed
EP-3198658-B1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS ENI SPA (IT) 2018-12-12 — — EP disclosed
US-20170250300-A1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS ENI S.P.A. (IT) 2017-08-31 — — US disclosed
US-20170250300-A1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS ENI S.P.A. (IT) 2017-08-31 — — US disclosed
US-20170250300-A1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS ENI S.P.A. (IT) 2017-08-31 — — US disclosed
EP-3198658-A1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS ENI S.p.A. (IT) 2017-08-02 — — EP disclosed
WO-2016046310-A1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS ENI S.P.A. (IT) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250300-A1 LUMINESCENT SOLAR CONCENTRATOR COMPRISING DISUBSTITUTED BENZOHETERODIAZOLE COMPOUNDS SCO2, SCLY, SLC39A7 CYP1A1 1723/4885CYP1B1 1747/4885CYP1A2 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback